Henry Schein, Inc. (HSIC) Quick Ratio (Acid-Test): 0.76
Is Henry Schein, Inc.’s quick ratio (acid-test) high or low?
Henry Schein, Inc.'s quick ratio (acid-test) of 0.76 is 14% below its 5-year average of 0.88, near the low end of its 5-year range (0.76–1.00).
As of Tuesday, June 23, 2026. 1.30% below its 12-month average of 0.77.
HSIC Quick Ratio (Acid-Test) Chart
HSIC Average Quick Ratio (Acid-Test) Chart
HSIC Current vs Average Quick Ratio (Acid-Test) Chart
HSIC Quick Ratio (Acid-Test) Metrics
QUICK RATIO (ACID-TEST)
0.76
QUICK RATIO (ACID-TEST) AVG TTM
0.77
QUICK RATIO (ACID-TEST) AVG 3Y
0.86
QUICK RATIO (ACID-TEST) AVG 5Y
0.88
QUICK RATIO (ACID-TEST) AVG 10Y
0.85
QUICK RATIO (ACID-TEST) AVG 15Y
0.90
QUICK RATIO (ACID-TEST) AVG 20Y
0.97
CURRENT VS TTM AVG
-1.30%
CURRENT VS 3Y AVG
-11.88%
CURRENT VS 5Y AVG
-14.12%
CURRENT VS 10Y AVG
-10.40%
CURRENT VS 15Y AVG
-15.61%
CURRENT VS 20Y AVG
-21.81%
HSIC Competitors' Quick Ratio (Acid-Test)
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Henry Schein, Inc. (HSIC) | $8.96B | 0.76 | 0.77 | 0.86 | 0.88 |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.75B | 1.02 | 1.07 | 1.10 | 1.11 |
| Tempus AI, Inc. (TEM)vs › | $8.35B | 3.00 | 2.58 | 2.23 | 3.05 |
| Baxter International Inc. (BAX)vs › | $10.15B | 1.56 | 1.31 | 1.23 | 1.40 |
| Oscar Health, Inc. (OSCR)vs › | $7.63B | 0.95 | 0.93 | 1.04 | 1.20 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.60B | 4.19 | 4.52 | 4.42 | 3.69 |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | 0.37 | 0.33 | 0.35 | 0.35 |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.48B | 1.61 | 1.56 | 2.48 | 3.39 |
| Revvity, Inc. (RVTY)vs › | $11.05B | 1.40 | 2.21 | 2.02 | 1.79 |
| Align Technology, Inc. (ALGN)vs › | $12.44B | 1.24 | 1.17 | 1.11 | 1.16 |
Liquidity Comparison
Quick Ratio
0.76
Excludes inventory
Current Ratio
1.38
Includes inventory
Henry Schein, Inc. Quick Ratio (Acid-Test) Formula & Definition
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Henry Schein, Inc. Quick Ratio (Acid-Test) FAQ
- What is the quick ratio (acid-test) for Henry Schein, Inc. (HSIC)?
- The quick ratio (acid-test) for HSIC stock is 0.76.
- Is Henry Schein, Inc.'s quick ratio (acid-test) high or low?
- Henry Schein, Inc.'s quick ratio (acid-test) of 0.76 is 14% below its 5-year average of 0.88, near the low end of its 5-year range (0.76–1.00).
- What is the TTM average quick ratio (acid-test) for Henry Schein, Inc. (HSIC)?
- The TTM average quick ratio (acid-test) for HSIC stock is 0.77.
- What is the 3Y average quick ratio (acid-test) for Henry Schein, Inc. (HSIC)?
- The 3Y average quick ratio (acid-test) for HSIC stock is 0.86.
- What is the 5Y average quick ratio (acid-test) for Henry Schein, Inc. (HSIC)?
- The 5Y average quick ratio (acid-test) for HSIC stock is 0.88.
- What is the 10Y average quick ratio (acid-test) for Henry Schein, Inc. (HSIC)?
- The 10Y average quick ratio (acid-test) for HSIC stock is 0.85.
- What is the 15Y average quick ratio (acid-test) for Henry Schein, Inc. (HSIC)?
- The 15Y average quick ratio (acid-test) for HSIC stock is 0.90.
- What is the 20Y average quick ratio (acid-test) for Henry Schein, Inc. (HSIC)?
- The 20Y average quick ratio (acid-test) for HSIC stock is 0.97.
Henry Schein, Inc. Quick Ratio (Acid-Test) History
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2025-12-27 | 0.76 |
| 2024-12-28 | 0.78 |
| 2023-12-31 | 1.00 |
| 2022-12-31 | 0.91 |
| 2021-12-31 | 0.86 |
| 2020-12-31 | 1.00 |
| 2019-12-31 | 0.88 |
| 2018-12-31 | 0.86 |
| 2017-12-31 | 0.76 |
| 2016-12-31 | 0.72 |
| 2015-12-31 | 0.80 |
| 2014-12-31 | 0.89 |
| 2013-12-31 | 1.02 |
| 2012-12-31 | 1.02 |
| 2011-12-31 | 1.04 |
| 2010-12-31 | 1.11 |
| 2009-12-31 | 1.33 |
| 2008-12-31 | 1.13 |
| 2007-12-31 | 1.26 |
| 2006-12-31 | 1.31 |
| 2005-12-31 | 1.49 |
| 2004-12-31 | 1.36 |
| 2003-12-31 | 1.48 |
| 2002-12-31 | 1.66 |
| 2001-12-31 | 1.45 |
| 2000-12-31 | 1.40 |
| 1999-12-31 | 1.41 |
| 1998-12-31 | 1.44 |
| 1997-12-31 | 1.33 |
| 1996-12-31 | 1.56 |
Related Metrics
About Henry Schein, Inc.
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Andrea Albertini